ASH Group Meetings

Join Us At ASH 2025

December 6 to 9, Guidepoint Insights will be hosting a series of group meetings featuring KOLs who will dive deeper into ASH 2025 updates.

    Saturday, December 6th
    9:00 AM ET - Dr. Marc Braunstein
    • Multiple Myeloma | Attending Physician - Hematology, NYU Winthrop Hospital
    9:00 AM ET - Dr. Christine Duncan
    • Sickle Cell | Associate Professor of Pediatrics, Harvard Medical School
    10:00 AM ET - Dr. Srinivas Tantravahi
    • Leukemias, MPN / SM | Hematology Specialist and Associate Professor, The University Of Utah
    10:00 AM ET - Dr. David Sallman
    • AML / MDS | Associate Member, H. Lee Moffitt Cancer Center and Research Institute Hospital Inc.
    11:00 AM ET - Dr. John Mascarenhas
    • MPN/AML | Professor of Medicine, Icahn School of Medicine at Mount Sinai
    11:00 AM ET - Dr. Maximilian Stahl
    • Leukemia, Malignancy Myeloma | Director of the Leukemia and Myeloid Malignancy Program of the Yale Cancer Center, Yale School of Medicine
    12:00 PM ET - Dr. Douglas Tremblay
    • MPN / SM / AM / CML | Assistant Professor of Medicine, Icahn School of Medicine at Mount Sinai
    12:00 PM ET - Dr. Joshua Brody
    • Lymphoma | Associate Professor of the Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai
    1:00 PM ET - Dr. Ashwin Kishtagari
    • MPN / SM / AML / MDS | Assistant Professor of Medicine, Vanderbilt University Medical Center
    1:00 PM ET - Dr. Preet Chaudhary
    • Novel CAR-Ts | Professor Medicine and Chief of the Nohl Division of Hematology & Center for Blood Diseases, Keck School of Medicine of USC
    2:00 PM ET - Dr. Marco Davila
    • CAR-Ts | Senior Vice President and Associate Director of Translational Research, Roswell Park Comprehensive Cancer Center
    2:00 PM ET - Dr. Claire Harrison
    • MPN / SM | Professor of Myeloproliferative Neoplasms and Clinical Director, Guy's And St Thomas' NHS Foundation Trust
    3:00 PM ET - Dr. Amit Patel
    • CAR-Ts | MAHSC Honorary Clinical Chair, University of Manchester
    3:00 PM ET - Dr. Izidore Lossos
    • Lymphoma | Professor of Medicine, Chief of Lymphoma Section and Head of the Lymphoma Program at the Sylvester Comprehensive Cancer Center, University of Miami
    4:00 PM ET - Dr. Andrew Lipsky
    • CLL and Lymphoma | Assistant Professor of Medicine, Columbia University Medical Center
    Sunday, December 7th
    9:00 AM ET - Dr. Justin Kaner
    • Leukemias, MPN / SM / AML / MDS | Medical Oncologist and Assistant Professor of Clinical Medicine, Weill Cornell Medicine
    9:00 AM ET - Dr. Richard Drachtman
    • Sickle Cell | Clinical Section Chief of the Pediatric Hematology-Oncology Division, Rutgers Cancer Institute of New Jersey
    10:00 AM ET - Dr. Joshua Sasine
    • CAR-Ts | Assistant Professor of Medicine and Founder & Co-Director of the CAR-T Program, Cedars-Sinai Health System
    10:00 AM ET - Dr. Nirmish Shah
    • Sickle Cell | Assistant Professor of Medicine and Pediatrics, Duke University
    11:00 AM ET - Dr. Sunil Iyer
    • Leukemias, MPN / SM | Hematologist-Oncologist & Assistant Professor of Medicine, Columbia University
    11:00 AM ET - Dr. Ran Reshef
    • Cell Therapy | Professor of Medicine, Columbia University Medical Center
    12:00 PM ET - Dr. William Matsui
    • Hematologic Malignancy | Vice Dean of Research, Dell Medical School
    12:00 PM ET - Dr. Thomas Leblanc
    • Leukemias, MPN / SM / MDS | Associate Professor of Medicine with Tenure, Duke University Medical Center
    1:00 PM ET - Dr. Koichi Takahashi
    • Leukemias, MPN / SM / AML / MDS | Associate Professor, The University of Texas MD Anderson Cancer Center
    1:00 PM ET - Dr. Gurbakhash Kaur
    • Stem Cell, Immunotherapy, CAR-Ts, Multiple Myeloma | Assistant Professor of Internal Medicine, Icahn School of Medicine at Mount Sinai
    2:00 PM ET - Dr. Akshay Sharma
    • Gene Therapy, Bone Marrow, Sickle Cell | Clinical Fellow of Pediatric Hematology Oncology, St. Jude Children's Research Hospital Inc.
    2:00 PM ET - Dr. Ravi Vij
    • Multiple Myeloma | Professor of Medicine, Washington University at St. Louis
    3:00 PM ET - Dr. Ryan Jacobs
    • CLL / Lymphoma | Associate Professor of the Department of Hematology, Wake Forest University Medical School
    4:00 PM ET - Dr. Evan Chen
    • Leukemias, MPN / SM / AML / MDS | Attending Physician, Dana-Farber Cancer Institute Inc.
    Monday, December 8th
    9:00 AM ET - Dr. Marco Ruella
    • Lymphoma, Leukemias, MPN / SM | Associate Professor of Medicine, University of Pennsylvania
    9:00 AM ET - Dr. Rory Shallis
    • Leukemias, MPN / SM / MDS | Assistant Professor, University of South Florida
    10:00 AM ET - Dr. Andrew Kuykendall
    • MPN / SM | Assistant Member, Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute Hospital Inc.
    10:00 AM ET - Dr. Farhad Ravandi
    • Leukemias | Professor of Medicine, The University of Texas MD Anderson Cancer Center
    11:00 AM ET - Dr. Jeffrey Wolf
    • Multiple Myeloma | Staff Physician, The University of California at San Francisco
    12:00 PM ET - Dr. Ronald Hoffman
    • Leukemias, MPN / SM | Albert A. and Vera G. List Professor of Medicine &
      Professor of Medicine in Hematology and Medical Oncology &
      Director of the Myeloproliferative Disorders Research Program, Icahn School of Medicine at Mount Sinai
    1:00 PM ET - Dr. Sherif Badawy
    • Non-Malignant Hematology | Associate Professor in the Department of Pediatrics, Northwestern University Feinberg School of Medicine
    2:00 PM ET - Dr. Saurabh Dahiya
    • CAR-Ts | Associate Professor of Medicine & Clinical Director of Cancer Cell Therapy, Stanford University School of Medicine
    3:00 PM ET - Dr. Ben Samelson-Jones
    • Hemophilia | Assistant Professor of Pediatrics, University of Pennsylvania
    4:00 PM ET - Dr. Andrew Branagan
    • Multiple Myeloma, Lymphoma | Clinical Investigator and Medical Director, Massachusetts General Hospital
    4:00 PM ET - Dr. Elias Jabbour
    • AML/MDS, CML, ALL | Associate Professor, The University of Texas MD Anderson Cancer Center

    *ASH Group Meetings will be 50 minutes long and available only to attendees. Group meetings are not recorded and transcripts will not be available following the event.